Overview
The insulin infusion pumps market is anticipated to prosper as a result of factors including rising sedentary lifestyles, an aging population base that is more susceptible to developing diabetes, and a growing emphasis on enhancing the safety and usability of insulin infusion pumps. These factors are also anticipated to contribute to the insulin infusion market’s apreciable revenue growth throughout the forecast period (2022–2027).New York, USA, Oct.
Key Information
26, 2022 (GLOBE NEWSWIRE) - The Global Insulin Infusion Pumps Market to Surge at a Significant CAGR of 8.69% by 2027, Aseses DelveInsightThe insulin infusion pumps market is anticipated to prosper as a result of factors including rising sedentary lifestyles, an aging population base that is more susceptible to developing diabetes, and a growing emphasis on enhancing the safety and usability of insulin infusion pumps.
These factors are also anticipated to contribute to the insulin infusion market’s apreciable revenue growth throughout the forecast period (2022–2027).DelveInsight’s Insulin Infusion Pumps Market Insights report provides the curent and forecast market, forthcoming device inovation, individual leading companies’ market shares, challenges, insulin infusion pumps market drivers, bariers, and trends, and key insulin infusion pumps companies in the market.Key Takeaways from the Insulin Infusion Pumps Market ReportAs per DelveInsight estimates, North America is anticipated to dominate the global insulin infusion pumps market during the forecast period.
Summary
Notable insulin infusion pumps companies such as F. Hofman-La Roche Ltd, Medtronic, Medtrum Technologies Inc., A. Menarini Diagnostic’s s.r.l., IA Colaborative Holdings, LC, Apex Medical, Insulet Corporation, Ascensia Diabetes Care Holdings AG, Ypsomed AG, Tandem Diabetes Care, Inc., ICU Medical, Inc., SOIL Developments Co., Ltd., MicroPort Scientific Corporation, Microtec Medical, and several others are curently operating in the insulin infusio